Tezspire Treats Chronic Sinus Symptoms With Nasal Polyps

Watchdoq March 2, 2025
(MedPage Today) -- SAN DIEGO -- Tezepelumab (Tezspire) reduced nasal polyps and symptoms in severe chronic rhinosinusitis while also decreasing need for further treatments, the WAYPOINT trial showed.
The monoclonal antibody against thymic stromal...

Read Full Article